Skip navigation
MOST POPULAR RELATED TAGS
  • TOPICS
  • SECTORS
  • COMPANIES

Current DateTime: 02:01:04 10 Feb 2012
LinksList Documentid: 25124396
Expiration DateTime: 2/10/2012 2:03:56 PM

ABOUT THE CNBC STOCK BLOG

The CNBC Stock Blog is a cross-section of expert opinions and insights from our TV and Web site coverage. This blog includes posts written by and about top analysts and strategists, super-investors and CNBC's own market mavens. You'll find stock picks, news about publicly-traded companies, commodities, hot sectors, ETFs and the latest options action.
Loading...
Loading...
Loading...
Loading...

RSS FEED

» Help

Current DateTime: 02:01:04 10 Feb 2012
LinksList Documentid: 30328029

CNBC EXPLAINS


Current DateTime: 02:01:04 10 Feb 2012
LinksList Documentid: 44105194

CNBC Stock Blog

Text Size
Oct.30
11:58 AM ET
Thursday, 30 Oct 2008

Five Stocks to Fight The Recession

Posted By:Andrew Fisher

The nation may be facing a long, deep recession, but Kiplinger's Personal Finance says some companies are positioned to survive and thrive.  The publication has singled out the stocks of five such companies.

"These are all 11-digit cash stashes," executive editor Manuel Schiffres explained to CNBC.  "At least $10 billion in cash; that's after debt."

Recommendations:

Topping the list is Exxon Mobil [XOM  Loading...      ()   ].

"Exxon's shares are off only 22 percent from their 52-week high," Schiffres pointed out.  "Exxon is a stable company, $37 billion in cash...it's very well managed."

Then there's Cisco Systems [CSCO  Loading...      ()   ], with $19 billion in cash reserves.

"Clearly, there are concerns that sales of routers and switchers will suffer in a weaker economy," he said, but added, "This is about as cheap as you can get for Cisco; one fund manager described this as 'a no-brainer.'"

Apple [AAPL  Loading...      ()   ] is another standout.

"Obviously, you know the story:  iPod, iPhone, Macs, a great innovator, tremendous earnings growth in recent years," he said.  "Apple could announce a major buyback program sometime in the next year or so."

The most controversial stock on the list could be drugmaker Pfizer [PFE  Loading...      ()   ].

"The stock has been as dull as aspirin for the last eight years," he said.  "The case for Pfizer is it's dirt-cheap...it's not going out of business...its pipeline of new drugs is probably stronger than most people give it credit for, and it could well announce another big cost-reduction program."

Rounding out the list is Google [GOOG  Loading...      ()   ].

Disclosures:

Disclosure information for Manuel Schiffres was not immediately available.

Disclaimer

© 2012 CNBC.com



Current DateTime: 09:37:12 10 Feb 2012
LinksList Documentid: 29778428

Current DateTime: 09:37:12 10 Feb 2012
LinksList Documentid: 29779196

Current DateTime: 11:35:13 10 Feb 2012
LinksList Documentid: 29779197

Current DateTime: 09:37:12 10 Feb 2012
LinksList Documentid: 29779199
CNBCCNBC
About CNBC  |  Site Map  |  Video Reprints   |  Advertise  |  Help  |  Contact
Privacy Policy  |     |  Terms of Service  |  Independent Programming Report
  Data is a real-time snapshot  *Data is delayed at least 15 minutes
Global Business and Financial News, Stock Quotes, and Market Data and Analysis

© 2012 CNBC LLC.  All Rights Reserved.
A Division of NBCUniversal
Thomson ReutersThomson Reuters